A real honour to give a keynote lecture at the ESC Heart & Stroke meeting in Milan!

Amazing session on Equity in Cardiovascular and Cerebrovascular Medicine🌏🚻 👏@DrBenjaminTan @B_Corica @GiulioFRomiti #ESCHeartAndStroke @JacopoImberti @MProiettiMD @escardio @ESCWGThrombosis @dariobongio @PanteleimonPap2 @LiverpoolCCS

⏰There is still time to register! #HeartAndStroke and EuroThrombosis 2025 Congress 15-16th November, Milan, Italy 🖇️ https://t.co/hCPsW2eVho @LiverpoolCCS @escardio @ESCWGThrombosis @JacopoImberti @Fra_Vitali90 @L_Bergamaschi @annapodlasek

Are teaching, research, and clinical work mutually exclusive? I’ve found them inseparable. Teaching sharpens thought, research improves patient care, and clinical work gives it purpose. Grateful to @NUSMedicine for the Teaching Excellence Award and my students who inspire me.

Just Accepted! 🫀Meta-analysis finds PFO closure is associated with a ⬇️reduced risk of recurrent stroke compared to antithrombotic therapy alone in patients over 60 🔎Most studies were observational - more RCTs needed Read more here👇 https://t.co/Q1efhF07IE @behnam_jazayeri

Several noninvasive methods for the assessment of liver fibrosis have been developed. They can be classified into two distinct but complementary approaches: blood-based methods, which include derived laboratory-based risk scores or biomarkers; and imaging methods, which are based

🧠👉Drug-coated balloon may ⬇️reduce restenosis risk in symptomatic patients with severe vertebral artery origin stenosis compared to bare-metal stent Read more here!👇 https://t.co/b1pjJYJtbr @DrLiqunJiao

🫀Study finds cardiac computed tomography a viable option for identifying high-risk structural sources of cardioembolism in ischemic stroke patients 👉Diagnostic yield of CCTA for detecting high-risk cardioaortic sources was 15.5% https://t.co/YU1RVbJPyE @KhansaOsmanMD

So true

Valuable insights on the HIGH long term risk of recurrent ischemic #stroke for young survivors @SAYA_stroke Higher rates than what was seen in the FUTURE study. Driven by early/mid life atherosclerosis?@DrBenjaminTan

ARTESIA trial and sub-analysis in people with prior AIS/TIA - Does the amount of #afib matter when deciding on a DOAC vs ASA to reduce #stroke risk? https://t.co/AE9Qaefri4 https://t.co/oHMq99rduC On balance, Apixaban is better, but the margin is narrower than with perm AF

Genomic variants in the LDL receptor are the big driver of atherosclerosis, but most were previously unclassified for their impact. Today @ScienceMagazine nearly all 17,000 variants (!) were assessed functionally, which markedly improves the diagnosis for familial high

#FlashbackFriday ! 🧠Study shows young adults with ischemic #stroke face long-term risk of recurrent cerebrovascular events Read more here!👇 https://t.co/zie35f9saF @DrBenjaminTan

🧠 World Stroke Day reminds us that #stroke is not only a brain disease — it’s a cardiovascular challenge too At #ESCStroke, we work to strengthen the heart–brain connection through science and collaboration💙 🖇️ https://t.co/QMSEE4QWVh #WorldStrokeDay @escardio @WorldStrokeOrg

It worked. Stem cells (mesenchymal) given to patients with a large heart attack reduced major adverse events in a randomized trial vs standard care https://t.co/ycKZKshxiX

#WorldStrokeDay: Stroke Prevention Doubles as Dementia Prevention Check out our latest #BloggingStroke post by contributor @maddyrussell16. #stroke #AHAJournals https://t.co/EF2lKABMmG

#WorldStrokeDay: Blood Pressure Control: The Cornerstone of Stroke and Cognitive Protection Check out our latest #BloggingStroke post, by contributor @romilsingh1892. #stroke #AHAJournals https://t.co/MZgpTJahs7

⏱️ #WorldStrokeDay – every minute counts.Every 2 seconds, someone has a #stroke. Delay = loss of brain, loss of life. 👉Facial weakness 👉Arm weakness 👉Slurred speech Recognition & #ActFAST save lives. https://t.co/81uqud3JJf #StrokeActionNow @WorldStrokeOrg @WStrokeCampaign

Patent Foramen Ovale and Stroke: A Review https://t.co/8v5PxiAmBx

Waiting room automated BP measurement is just as accurate as isolated-room readings for diagnosing hypertension - and superior to standard office BP. A practical solution when ABPM or home monitoring is not available. @sricomar @jacintoferpa @EnrRodilla https://t.co/YSgsauvAqF